(19)
(11) EP 1 773 307 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.12.2014 Bulletin 2014/51

(45) Mention of the grant of the patent:
15.10.2014 Bulletin 2014/42

(21) Application number: 05768530.7

(22) Date of filing: 29.07.2005
(51) International Patent Classification (IPC): 
A61K 31/133(2006.01)
A61P 37/00(2006.01)
 A61K 47/10(2006.01)
A61P 37/06(2006.01)
(86) International application number:
PCT/EP2005/008267
(87) International publication number:
WO 2006/010630 (02.02.2006 Gazette 2006/05)

(54)

COMPOUND FORMULATIONS OF 2-AMINO-1,3-PROPANEDIOL COMPOUNDS

VERBINDUNGSFORMULIERUNGEN AUS 2-AMINO-1,3-PROPANEDIOL-VERBINDUNGEN

PREPARATIONS DE COMPOSES A BASE DE 2-AMINO-1,3-PROPANEDIOL

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 30.07.2004 US 592991 P

(43) Date of publication of application:
18.04.2007 Bulletin 2007/16

(60) Divisional application:
14178519.6

(73) Proprietor: Novartis AG
4056 Basel (CH)

(72) Inventors:
  • BURANACHOKPAISAN, Thitiwan
    Morristown, NJ 07960 (US)
  • DANNENFELSER, Rose-Marie
    Bloomfield, NJ 07003 (US)
  • LI, Ping
    Basking Ridge, NJ 07920 (US)

(74) Representative: Rouquayrol, Céline Hélène et al
Novartis Pharma AG Lichtstrasse 35
4056 Basel
4056 Basel (CH)


(56) References cited: : 
EP-A- 0 627 406
EP-A- 0 990 440
EP-A- 1 195 165
WO-A-03/062248
GB-A- 2 400 318
 EP-A- 0 812 588
EP-A- 1 050 301
WO-A-02/18395
WO-A-03/062252
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).